Matrix metalloproteinases in serum and the follicular fluid of women treated by in vitro fertilization

[1] Baka S(2010)Matrix metalloproteinases 2 and 9 and their tissue inhibitors in the follicular fluid of patients with polycystic ovaries undergoing in vitro fertilisation In Vivo 24 293-6

[2] Zourla K(2009)Intrafollicular levels of matrix metalloproteinases-2 and -9 in patients with polycystic ovaries are not associated with pregnancy rate during IVF cycle In Vivo 23 89-92

[3] Kouskouni E(2002)Control of MMP-9 expression at the maternal-fetal interface J Reprod Immunol 55 3-10

[4] Makrakis E(2001)Cellular localization of gelatinases and tissue inhibitors of metalloproteinases during follicular growth, ovulation, and early luteal formation in the rat Biol Reprod 65 855-65

[5] Demeridou S(2003)The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle Endocr Rev 24 428-65

[6] Tzanakaki D(2004)Intrafollicular expression of matrix metalloproteinases and their inhibitors in normally ovulating women compared with patients undergoing in vitro fertilization treatment Eur J Endocrinol 151 87-91

[7] Hassiakos D(2000)Gelatinase B deficiency impairs reproduction J Clin Invest 106 627-628

[8] Creatsas G(2009)The influence of early cleavage on embryo developmental potential and IVF/ICSI outcome J Assist Reprod Genet 26 437-41

[9] Baka S(2011)Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome Mol Cell Biochem 353 251-7

[10] Zourla K(2002)Role of matrix metalloproteinase 2 in the ovulatory folliculo-luteal transition of ewes Reproduction 124 347-352

[1] Baka S(2010)Matrix metalloproteinases 2 and 9 and their tissue inhibitors in the follicular fluid of patients with polycystic ovaries undergoing in vitro fertilisation In Vivo 24 293-6

[2] Zourla K(2009)Intrafollicular levels of matrix metalloproteinases-2 and -9 in patients with polycystic ovaries are not associated with pregnancy rate during IVF cycle In Vivo 23 89-92

[3] Kouskouni E(2002)Control of MMP-9 expression at the maternal-fetal interface J Reprod Immunol 55 3-10

[4] Makrakis E(2001)Cellular localization of gelatinases and tissue inhibitors of metalloproteinases during follicular growth, ovulation, and early luteal formation in the rat Biol Reprod 65 855-65

[5] Demeridou S(2003)The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle Endocr Rev 24 428-65

[6] Tzanakaki D(2004)Intrafollicular expression of matrix metalloproteinases and their inhibitors in normally ovulating women compared with patients undergoing in vitro fertilization treatment Eur J Endocrinol 151 87-91

[7] Hassiakos D(2000)Gelatinase B deficiency impairs reproduction J Clin Invest 106 627-628

[8] Creatsas G(2009)The influence of early cleavage on embryo developmental potential and IVF/ICSI outcome J Assist Reprod Genet 26 437-41

[9] Baka S(2011)Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome Mol Cell Biochem 353 251-7

[10] Zourla K(2002)Role of matrix metalloproteinase 2 in the ovulatory folliculo-luteal transition of ewes Reproduction 124 347-352